Abstract

Our multiplex IHC assays are aimed to more accurately detect basal-like breast cancer associated iwth lower disease-free survival and overall survival. The goal is to develop an automated assay by incorporating our assay into commercially available automated instruments that stain, scan and analyze the sample.

  Funding Agency

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Small Business Innovation Research – Phase II (N44)
Project #
261201200089C-0-0-1
Application #
8566310
Study Section
Project Start
2012-09-28
Project End
2014-09-27
Budget Start
Budget End
Support Year
Fiscal Year
2012
Total Cost
$998,116
Indirect Cost

  Institution

Name
Solulink Biosciences
Department
Type
DUNS #
065437373
City
San Diego
State
CA
Country
United States
Zip Code
92121